Moxibustion Plus Cupping in Convalescent Patients With COVID-19
1 other identifier
interventional
60
1 country
1
Brief Summary
This trial is designed to evaluate the efficacy and safety of moxibustion plus cupping in the convalescence of COVID-19.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable covid19
Started May 2020
Typical duration for not_applicable covid19
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 20, 2020
CompletedFirst Posted
Study publicly available on registry
May 5, 2020
CompletedStudy Start
First participant enrolled
May 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedNovember 24, 2021
August 1, 2021
1.6 years
April 20, 2020
November 16, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The proportion of responder at week 4
The responder is defined as the participants with ≥ 50% average VAS decrease of chest tightness and fatigue compared with baseline. The VAS ranges from 0 to 100.
baseline, week 4
Secondary Outcomes (15)
The proportion of responder at week 8
baseline, week 8
The change in the average VAS score of main symptoms from baseline
baseline, week 4, week 8
The change in the severity VAS score of main symptoms from baseline
baseline, week 4, week 8
The change in the average VAS score of other symptoms from baseline
baseline, week 4, week 8
The change in mean frequency of diarrhea and spontaneous bowel movements from baseline
baseline, week 4, week 8
- +10 more secondary outcomes
Study Arms (2)
Moxibustion plus Cupping
EXPERIMENTALMoxibustion plus cupping and basic therapy (rehabilitation direction and basic breathing exercise) once a day for 4 weeks (28 sessions).The moxibustion plus cupping treatments were divided into 2 alternating formulas: A: Monday, Wednesday, Friday and Sunday: moxibustion on bilateral Fengmen (BL12), Feishu (BL13) and Pishu(BL20) B: Tuesday, Thursday and Saturday: moxibustion on Zhongwan (RN12), Qihai (RN6), bilateral Tianshu(ST25) and Zusanli(ST36) + cupping on bilateral Feishu(BL13) Geshu(BL17) Pishu(BL20) The 2 formulas were used alternatively every other day, 7 times per week, for 4 weeks. Moxibustion acupoint addition: profuse sweating added Fuliu (KI7), insomnia added Shenmen(HT7) anxiety or depression added Neiguan (PC6).
Basic therapy
NO INTERVENTIONBasic therapy: rehabilitation direction and basic breathing exercise.
Interventions
Moxibustion: The burning of a small, thimble sized, smoldering plug of dried leaves on the skin at an acupuncture point. Usually the plugs contain leaves of mugwort or moxa. Cupping takes the pot as a tool, uses the combustion to remove the air in the pot, causes a negative pressure, and makes it adsorb on the skin of the acupoints. Use"Baixiaojiu"moxibustion on each acupoint for 10-15 minutes, the temperature of moxibustion should be adjusted within patient's tolerance level. Use diameter of 5-6 cm acuum cupper to cupping on each acupoint for 5-8 minutes.
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of the convalescence of COVID-19 (defined by the Chinese Guideline for COVID-19 in 2020 Trial Version 7).
- years old;
- chest tightness/fatigue/shortness of breath/cough, with at least 2 of the above symptoms and the average VAS score (last 48 hours) ≥ 40 points;
- Volunteers with informed consent;
You may not qualify if:
- Surgery in the lung that affects lung function;
- Rely on mechanical ventilation to maintain lung function;
- Chronic lung diseases affecting lung function;
- Diseases affecting heart function;
- Severe basic diseases;
- Resting heart rate \> 120/min, systolic blood pressure \> 180mmHg, diastolic blood pressure \> 100mmHg;
- Unstable angina or myocardial infarction in the past 1 month;
- Severe obesity (BMI\>30kg/m2);
- Allergic constitution;
- Pregnant or lactating women;
- Disabled patients;
- Mentally ill Patients;
- Participating in other clinical trials;
- Poor compliance or other complicate conditions according to the researchers.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Guang'anmen Hospital of China Academy of Chinese Medical Scienceslead
- Hubei Hospital of Traditional Chinese Medicinecollaborator
- Hubei Provincial Hospital of Integrated Chinese & Western Medicinecollaborator
- Wuhan Hospital of Traditional Chinese Medicinecollaborator
- Wuhan Third Hospitalcollaborator
- Huangshi Hospital of Traditional Chinese Medicinecollaborator
- Yichang Hospital of Traditional Chinese Medicinecollaborator
- Ezhou Hospital of Traditional Chinese Medicinecollaborator
- Hunan University of Traditional Chinese Medicinecollaborator
- The Hospital of Jiangxi University of Chinese Medicinecollaborator
Study Sites (1)
Hubei Province Hospital
Wuhan, Hubei, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Xiaopin Wang
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- PRINCIPAL INVESTIGATOR
Zhongyu Zhou
Hubei Hospital of Traditional Chinese Medicine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Secretary of Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Study Record Dates
First Submitted
April 20, 2020
First Posted
May 5, 2020
Study Start
May 10, 2020
Primary Completion
December 1, 2021
Study Completion
December 1, 2021
Last Updated
November 24, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- It depends.
- Access Criteria
- It depends.
Individual participant data are available on reasonable request. You can send e-mail to us if you have any question.